26.08.2021 Economic Outlook 2-21:A bumpy way out of the crisis On the way out of the crisis, the differences in demand, inflation risks and policy prospects are noticeable. Are you representing a MIFID II Investment firm? Register for free Credit research today! 23.09.2021 Short comment: Rate hike and hiher rate path from Norges Bank Norges Bank raised the rate to 0.25%, as expected. Oddmund Berg Economist 22.09.2021 US Snapshot: Fed hints at tapering “soon” & more hikes Fed says that tapering may soon be warranted. Knut Magnussen Senior Economist 09.09.2021 Short comment: ECB moderates the pace of PEPP purchases We expect the PEPP to be ended in March 2022. Kjersti Haugland Chief Economist 10.09.2021 Short comment: Core inflation fell to 1.0% in August This was as expected by Norges Bank. Oddmund Berg Economist Macro, FX and Commodities Global Date Report Analyst Type 07:45 DNB MacroScore November: Weaker activity, higher inflation Knut Magnussen Global 19.11.2021 Weekly calendar, 22 – 26 November Global 05.11.2021 Weekly Calendar 7 – 12 November: Inflation, amended Norwegian budget proposal an... Global 29.10.2021 Weekly Calendar 1-5 November: Fed, Bank of England and Norges Bank Global 26.10.2021 DNB MacroScore October: Marked turnaround for the global score Knut Magnussen Global See more reports Other public reports Commissioned Equity Research Date Report Analyst Type 14.11.2021 Isofol Medical: Intensifying precommercial activities David Martinsson Commissioned 10.11.2021 Freja eID Group: Entering the next phase Joachim Gunell Commissioned 03.11.2021 VEF: Many shots at goal Joachim Gunell Commissioned 02.11.2021 Atvexa: Perceived political risk Karl-Johan Bonnevier Commissioned 01.11.2021 Episurf Medical: Q3 report a non-event Patrik Ling Commissioned 28.10.2021 IAR Systems: Winds of change Joachim Gunell Commissioned 22.10.2021 Nexam Chemical : Q3 is history, opportunities ahead Mattias Holmberg Commissioned 15.10.2021 Episurf Medical: Financial position secured Patrik Ling Commissioned 03.09.2021 Episurf Medical: New long-term data strengthens the story Patrik Ling Commissioned 24.08.2021 Isofol Medical: Shifting focus from clinical to commercial development David Martinsson Commissioned DNB Markets’ FICC Macro, FX and Commodity Research The DNB Markets’ FICC Macro, FX and Commodity Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys. Kjersti Haugland Chief Economist Knut Magnussen Senior Economist Kyrre Aamdal Senior Economist Magne Østnor Currency Strategist Ingvild Borgen Gjerde FX and Interest Rate Analyst Helge André Martinsen Senior Analyst Oddmund Berg Economist Kelly Ke-Shu Chen Economist News 24.09.2020 A sustainable comeback September hasn’t yet come to an end, but it is by far a record month when it comes to sustainable bond issuance. 11.08.2020 DNB ranked #2 in the Institutional Investor survey The Institiutional Investor survey for Nordic equities 2020 is out, and we thank all our clients for your continued strong support! 16.06.2020 NOK 7.7bn carve-out acquisition of Veidekke Eiendom DNB Markets acted as Financial Advisor to Residential Holding in the NOK 7.7bn carve-out acquisition of Veidekke Eiendom from Veidekke ASA and... 21.10.2019 DNB Salmon Farming Of The Future - Presentations Presentations from the conference Salmon Farming Of The Future 21 October 2019 are now avaiable. 10.10.2019 DNB Nordic High Yield Bond Conference - Presentations Presentations from DNB`s 5th annual Nordic High Yield Bond conference are now available. 30.08.2019 Nordic TMT Conference - Presentations Presentations from DNB's 15th annual Nordic TMT Conference are available. What is DNB Alpha? DNB Alpha is an online research portal for institutional clients and partners of DNB Markets. Our macro research is publicly available. Please log in to access equity- and credit research, corporate access activities and events. Click here to request full access Video: Introduction to DNB Alpha DNB Markets Branches » Oslo » Foreign Branches Contact dnbalpha@dnb.no Follow us